Skip to main content
Genome&Company logo

Genome&Company — Investor Relations & Filings

Ticker · 314130 ISIN · KR7314130006 KO Manufacturing
Open in API
Filings indexed 427 across all filing types
Latest filing 2026-05-14 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 314130

About Genome&Company

http://genomecom.co.kr/

Genome&Company is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics. The company's research and development pipeline is centered on two primary platforms: microbiome-based pharmaceuticals and novel immune checkpoint inhibitors for immuno-oncology. Its drug candidates are derived from its proprietary microbiome platform and are aimed at treating a range of diseases, with a significant focus on cancer. In addition to its pharmaceutical programs, the company develops and markets consumer healthcare products, including dietary supplements and cosmeceuticals, leveraging its expertise in microbes and probiotics.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 85% confidence The document is a Korean regulatory filing titled “정정신고” for the grant of stock options (주식매수선택권 부여에 관한 신고), detailing corrections to the terms and number of options granted, the grant conditions, and reflecting changes in total awards. This is a corporate announcement of a share‐based capital change (stock option issuance), not an earnings report, AGM material, or management change. It fits the “Share Issue/Capital Change” category (code SHA).
2026-05-14 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 75% confidence The document is a statutory disclosure under Korean law reporting on the grant (and subsequent amendment) of employee stock options by the company. It is not a financial report, earnings release, board change or insider transaction, but an announcement of a change in the company’s capital instruments via issuance of stock options. This fits the definition of Share Issue/Capital Change (SHA).
2026-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It includes detailed information about securities ownership, changes in holdings, and related dates. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange, indicating it is a formal ownership disclosure. This matches the description of a Major Shareholding Notification, which reports changes in significant share ownership levels. The document length is 2505 characters, which is consistent with a detailed ownership report rather than a brief announcement or a full financial report. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2026-04-30 Korean
전환청구권행사
Share Issue/Capital Change Classification · 85% confidence The document is a voluntary Korean disclosure detailing the exercise of convertible bond conversion rights, showing number of shares issued upon conversion, outstanding convertible bond balances, issue percentages, and related dates. This constitutes a capital structure change via issuance of new shares. It is not a full financial report, earnings release, or management commentary, but rather a specific announcement of share issuance through bond conversions. Therefore, it should be classified as a Share Issue/Capital Change (SHA).
2026-04-28 Korean
전환가액의조정
Capital/Financing Update Classification · 82% confidence The document is a corporate disclosure detailing the adjustment of the conversion price and convertible share quantities for a tranche of convertible bonds (“전환사채”). It outlines the calculation basis, adjustment dates, and resulting new conversion price. This is not a full financial report, AGM materials, or earnings release but a specific update on a financing instrument (convertible debt), affecting the company’s capital structure. Therefore it fits the “Capital/Financing Update” category (CAP).
2026-04-20 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 90% confidence The document is a voluntary disclosure of the results of a securities issuance (third-party allotment of newly issued ordinary shares), detailing planned vs. actual number of shares and amount, payment date, and listing plan. This is a direct announcement of a new share issue/capital change, matching the “Share Issue/Capital Change” category.
2026-04-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.